Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare... Show more
MKKGY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The 10-day RSI Indicator for MKKGY moved out of overbought territory on January 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where MKKGY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MKKGY as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MKKGY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MKKGY advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
MKKGY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 251 cases where MKKGY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.842) is normal, around the industry mean (29.792). P/E Ratio (18.030) is within average values for comparable stocks, (74.095). Projected Growth (PEG Ratio) (2.620) is also within normal values, averaging (2.035). Dividend Yield (0.017) settles around the average of (0.029) among similar stocks. P/S Ratio (2.507) is also within normal values, averaging (116.680).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MKKGY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MKKGY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Industry PharmaceuticalsGeneric
A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.
| Ticker / NAME | Correlation To MKKGY | 1D Price Change % | ||
|---|---|---|---|---|
| MKKGY | 100% | -3.18% | ||
| MKGAF - MKKGY | 49% Loosely correlated | -5.63% | ||
| AMPH - MKKGY | 25% Poorly correlated | +1.15% | ||
| ZTS - MKKGY | 25% Poorly correlated | -2.02% | ||
| SUPN - MKKGY | 25% Poorly correlated | -0.78% | ||
| INDV - MKKGY | 24% Poorly correlated | +1.29% | ||
More | ||||
| Ticker / NAME | Correlation To MKKGY | 1D Price Change % |
|---|---|---|
| MKKGY | 100% | -3.18% |
| Pharmaceuticals: Generic industry (214 stocks) | 29% Poorly correlated | -0.59% |